Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
The Monthly: January 2025
10th Jan 2025
Real Estate Credit Investments (RECI)
January 2025 Monthly
10th Jan 2025
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
109: Where are we in the venture capital cycle? | Henry Whorwood of Beauhurst
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Oxford BioMedica
Life Sciences
Ready for CTL019 approval
24 Aug 2017
Tissue Regenix
Life Sciences
CellRight: Transforming US growth prospects
10 Aug 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Collagen Solutions Plc
Life Sciences
Transitioning to accelerated sustainable growth
By
Dr Martin Hall
25 Jul 2017
Alliance Pharma Plc
Life Sciences
International brands driving growth
By
Dr Martin Hall
24 Jul 2017
Allergy Therapeutics plc
Life Sciences
Strong sales drive market share gains
By
Dr Martin Hall
19 Jul 2017
Oxford BioMedica
Life Sciences
Major deal to supply Novartis CAR-T programmes
07 Jul 2017
Evgen Pharma
Life Sciences
Making clinical progress
By
Dr Martin Hall
21 Jun 2017
ValiRx
Life Sciences
Initiation: Developing novel cancer therapies
31 May 2017
Alliance Pharma Plc
Life Sciences
A transformational year driving growth
By
Dr Martin Hall
25 May 2017
Avacta Group plc
Life Sciences
Affimers 2 – Antibodies 0
By
Dr Martin Hall
24 May 2017
Collagen Solutions Plc
Life Sciences
Trading update indicates earnings above forecasts
By
Dr Martin Hall
11 May 2017
Prev
1
...
18
19
20
21
22
Next
